nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A national cross-sectional survey of financial toxicity among bladder cancer patients
|
Ehlers, Mark |
|
|
39 |
1 |
p. 76.e1-76.e7 |
artikel |
2 |
Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer
|
Morgans, Alicia K. |
|
|
39 |
1 |
p. 52-62 |
artikel |
3 |
Clinicopathological characteristics, prognosis, and chemosensitivity in patients with metastatic upper tract urothelial carcinoma
|
Li, Xu |
|
|
39 |
1 |
p. 75.e1-75.e8 |
artikel |
4 |
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates
|
Collà Ruvolo, Claudia |
|
|
39 |
1 |
p. 74.e1-74.e7 |
artikel |
5 |
Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapy
|
Tamura, Keita |
|
|
39 |
1 |
p. 78.e1-78.e8 |
artikel |
6 |
Evaluation of the clinical use of PET/CT with 68Ga-PSMA for the assessment of biochemical recurrence of low or intermediate-risk prostate cancer
|
Ribeiro, André Marcondes Braga |
|
|
39 |
1 |
p. 73.e9-73.e18 |
artikel |
7 |
Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patients
|
Smith, Angela B. |
|
|
39 |
1 |
p. 77.e1-77.e8 |
artikel |
8 |
Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer
|
Fujita, Naoki |
|
|
39 |
1 |
p. 75.e9-75.e16 |
artikel |
9 |
Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study
|
Gontero, Paolo |
|
|
39 |
1 |
p. 78.e17-78.e26 |
artikel |
10 |
Lessons learned from 40 years of managing chylous ascites following RPLND
|
Masterson, Timothy A. |
|
|
39 |
1 |
p. 1-2 |
artikel |
11 |
Nice to Virtually Meet You: Perception, Utilization, and Barriers in Telemedicine Use for New Diagnosis Oncology Patients During COVID-19
|
|
|
|
39 |
1 |
p. 3-5 |
artikel |
12 |
Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer
|
Deuker, Marina |
|
|
39 |
1 |
p. 75.e17-75.e25 |
artikel |
13 |
Optimizing the risk threshold of lymph node involvement for performing extended pelvic lymph node dissection in prostate cancer patients: a cost-effectiveness analysis
|
Hueting, Tom A. |
|
|
39 |
1 |
p. 72.e7-72.e14 |
artikel |
14 |
PD-L1 and VEGFR-2 expression in synchronous metastatic renal cell carcinoma treated with targeted therapy following cytoreductive nephrectomy
|
Jiang, Weixing |
|
|
39 |
1 |
p. 78.e9-78.e16 |
artikel |
15 |
Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era
|
Ishihara, Hiroki |
|
|
39 |
1 |
p. 77.e17-77.e25 |
artikel |
16 |
Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update
|
Powell, Isaac J. |
|
|
39 |
1 |
p. 34-40 |
artikel |
17 |
Prospective Validation of Clinical Usefulness of a Novel mRNA-based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder Cancer
|
Elsawy, Amr A. |
|
|
39 |
1 |
p. 77.e9-77.e16 |
artikel |
18 |
Prostate cancer presentation, treatment selection, and outcomes among men with HIV/AIDS: A clinical stage, race, and age-matched contemporary analysis
|
Ruden, Maria |
|
|
39 |
1 |
p. 73.e19-73.e25 |
artikel |
19 |
Pseudouridine as a novel biomarker in prostate cancer
|
Stockert, Jennifer A. |
|
|
39 |
1 |
p. 63-71 |
artikel |
20 |
Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia
|
González-Padilla, Daniel A. |
|
|
39 |
1 |
p. 76.e9-76.e14 |
artikel |
21 |
“Real-world” outcomes and prognostic indicators among patients with high-risk muscle-invasive urothelial carcinoma
|
Drakaki, Alexandra |
|
|
39 |
1 |
p. 76.e15-76.e22 |
artikel |
22 |
Relentlessly make yourself obsolete: Robot-assisted radical cystectomy, the emerging standard of care
|
Loughlin, Kevin R. |
|
|
39 |
1 |
p. 13-14 |
artikel |
23 |
Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma
|
Cheaib, Joseph G. |
|
|
39 |
1 |
p. 74.e9-74.e16 |
artikel |
24 |
Specificities of small cell neuroendocrine prostate cancer: Adverse prognostic value of TTF1 expression
|
Cancel, Mathilde |
|
|
39 |
1 |
p. 74.e17-74.e23 |
artikel |
25 |
The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings—Implications for the COVID-19 era
|
Savin, Ziv |
|
|
39 |
1 |
p. 73.e1-73.e8 |
artikel |
26 |
The role of surgical experience in patient selection, surgical quality, and outcomes in robot-assisted radical cystectomy
|
Posada Calderon, Lina |
|
|
39 |
1 |
p. 6-12 |
artikel |
27 |
The value and limitations of urothelial bladder carcinoma molecular classifications to predict oncological outcomes and cancer treatment response: A systematic review and meta-analysis
|
Kardoust Parizi, Mehdi |
|
|
39 |
1 |
p. 15-33 |
artikel |
28 |
Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity
|
Hajiran, Ali |
|
|
39 |
1 |
p. 72.e1-72.e5 |
artikel |
29 |
Urinary biomarkers in bladder cancer: A review of the current landscape and future directions
|
Ng, Kenrick |
|
|
39 |
1 |
p. 41-51 |
artikel |
30 |
Utilization of renal mass biopsy in patients with localized renal cell carcinoma: A population-based study utilizing the National Cancer Database
|
Patel, Devin N. |
|
|
39 |
1 |
p. 79.e1-79.e8 |
artikel |
31 |
Validation of “patient-reported outcomes via online questionnaire” as a urinary continence assessment and quality improvement tool following radical prostatectomy
|
Huynh, Linda My |
|
|
39 |
1 |
p. 72.e15-72.e20 |
artikel |